1. Home
  2. FSBW vs PRQR Comparison

FSBW vs PRQR Comparison

Compare FSBW & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

HOLD

Current Price

$40.15

Market Cap

295.4M

Sector

Finance

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$2.00

Market Cap

167.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBW
PRQR
Founded
1936
2012
Country
United States
Netherlands
Employees
537
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
295.4M
167.5M
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
FSBW
PRQR
Price
$40.15
$2.00
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$46.00
$6.80
AVG Volume (30 Days)
8.0K
445.9K
Earning Date
04-24-2026
05-07-2026
Dividend Yield
2.86%
N/A
EPS Growth
N/A
N/A
EPS
4.29
N/A
Revenue
$4,612,000.00
N/A
Revenue This Year
$14.94
N/A
Revenue Next Year
$10.47
$10.76
P/E Ratio
$9.45
N/A
Revenue Growth
44.80
N/A
52 Week Low
$36.72
$1.08
52 Week High
$44.22
$3.10

Technical Indicators

Market Signals
Indicator
FSBW
PRQR
Relative Strength Index (RSI) 60.35 63.59
Support Level $39.44 $1.91
Resistance Level $43.33 $1.99
Average True Range (ATR) 1.38 0.16
MACD 0.34 0.04
Stochastic Oscillator 100.00 78.75

Price Performance

Historical Comparison
FSBW
PRQR

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of First Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: